Journal of Endocrinological Investigation

, Volume 1, Issue 1, pp 39–45 | Cite as

Hypothalamic-pituitary-ovarian function in hyperprolactinemic women

  • Pietro Travaglini
  • B. Ambrosi
  • P. Beck-Peccoz
  • R. Elli
  • M. Rondena
  • R. Bara
  • G. Weber


Hypothalamic-pituitary-ovarian function, as well as other pituitary tropic hormone secretions, was examined in 27 hyperprolactinemic patients (17 with PRL-secreting tumor and 10 with so called functional hyperprolactinemia). Serum PRL levels ranged between 39 and 108 ng/ml in functional cases and between 34 and 2500 ng/ml in patients with pituitary adenoma. Basal serum LH, FSH and 17 β-estradiol levels did not differ from those recorded between days −14 and −10 in normally cycling women in functional cases, and were lowered in patients with pituitary tumor. LH response to GnRH (25μg iv) was normal in 7, impaired in 1 and exaggerated in 2 functional cases, and appeared normal in 9 and impaired in 8 tumoral cases. Two exaggerated FSH responses were seen in functional patients and 4 in patients with pituitary tumor. Estradiol benzoate administration (1 mg im) caused a significant fall in serum FSH and LH within 24 hr, but failed to induce serum LH increase within 96 hr in 11 out of 12 examined patients while a definite LH peak occurred within 48–72 hr in 7 patients retested after serum PRL normalization. Clomiphene citrate (100 mg/day for 5 days) administration caused a normal rise in serum LH, FSH and 17β-estradiol in 5 functional cases and in 1 case with pituitary tumor out of 9 patients tested. Normal pulsatility of serum LH was observed in 3 examined patients. In 3 normogonadotropic patients with PRL-secreting tumor, hCG + hMG administration (5000 + 150 IU im for 3 days) did not cause any significant increase in plasma 17β-estradiol while inducing a sharp rise in the same patients retested after serum PRL normalization. No abnormal changes in TSH, GH and ACTH secretion both in the basal state and after provocative stimuli were observed in patients with functional hyperprolactinemia, whereas in patients with pituitary tumors TSH secretion was impaired in 53% of cases, GH secretion in 71% and ACTH secretion in 29%. The present data along with previous reports in the literature suggest that high serum PRL can induce anovulation and amenorrhea by acting at both hypothalamic and ovarian levels.


Prolactin amenorrhea-galactorrhea functional hyperprolactinemia PRL-secreting tumors estrogen positive feedback Gn-RH clomiphene hypothalamic-pituitary-ovarian axis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rolland R., Schellekens L.A., Lequin R.M. Successful treatment of galactorrhoea and subsequent restoration of ovarian function by a new ergot alcaloid 2-brom-α-ergocriptine. Clin. Endocrinol. (Oxf) 3: 155, 1974.CrossRefGoogle Scholar
  2. 2.
    Thorner M.O., McNeilly A.S., Hagan G., Besser G.M. Longterm treatment of galactorrhoea and hypogonadism with bromocriptine. Br. Med. J. 2: 419, 1974.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Del Pozo E., Wyss H., Lancranjan I., Obolensky W., Varga L. Prolactin-induced luteal insufficiency and its treatment with bromocriptin: Preliminary Results. In: Crosignani P.G. and Mishell D.R. (Eds.), Ovulation in the Human. Academic Press, New York 1976, Serono Symposia vol. 8, p. 297.Google Scholar
  4. 4.
    Bohnet H.G., Schneider H.P.G. Prolactin as cause of anovulation. In: Crosignani P.G., Robyn C., (Eds.), Prolactin and Human Reproduction. Academic Press, New York, 1977, Serono Symposia, vol. 11, p. 153.Google Scholar
  5. 5.
    Boyar R.M., Kapen S., Finkelstein J.W., Sassin J.F., Fukushima D.K., Wetzman E.D., Hellman L. Hypotalamic-pituitary function in diverse hyperprolactinemic states. J. Clin. Invest. 53: 1588, 1974.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Bohnet M.G., Dahlen H.G., Wuttke W., Schneider M.P.G. Hyperprolactinemic anovulatory syndrome. J. Clin. Endocrinol. Metab. 42: 132, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    Glass M.R., Shaw R.W., Butt W.R., Edwards R.L., London D.R. An abnormality of oestrogen feed-back in amenorrhoea galactorrhoea. Br. Med. J. 3: 274, 1975.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Aono T., Miyake A., Shioji T., Kinugasa T., Onishi T., Kurachi K. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactor-rhea syndrome. J. Clin. Endocrinol. Metab. 42: 696, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Rolland R., Hammonds J. Demonstration of specific prolactin receptors in porcine granulosa cells and corpora lutea. Acta Endocrinol. (Suppl) (Kbh) 199: 101, 1975.Google Scholar
  10. 10.
    Saito T., Saxena B.B. Specific receptors for prolactin in the ovary. Acta Endocrinol. (Kbh) 80: 126, 1975.Google Scholar
  11. 11.
    McNatty K.P., Sawers R.S., McNeilly A.S. A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature 250: 653, 1974.PubMedCrossRefGoogle Scholar
  12. 12.
    McNatty K.P., McNeilly A.S., Sawers R.S. Prolactin and progesterone secretion by human granulosa cells in vitro. In: Crosignani P.G., Robyn C. (Eds.), Prolactin and Human Reproduction. Academic Press, New York, 1977, Serono Symposia, vol. 11, p. 109.Google Scholar
  13. 13.
    Midgley A.R. Jr. Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology 79: 10, 1966.PubMedCrossRefGoogle Scholar
  14. 14.
    Midgley A.R. Jr. Radioimmunoassay for human follicle stimulating hormone. J. Clin. Endocrinol. Metab. 27: 295, 1967.PubMedCrossRefGoogle Scholar
  15. 15.
    Sinha Y.N., Selby F.W., Lewis V.F., Vanderlaan W.P. A homologous RIA for human prolactin. J. Clin. Endocrinol. Metab. 36: 509, 1973.PubMedCrossRefGoogle Scholar
  16. 16.
    Hotchkiss J., Atkinson L.E., Knobil E. Time course of serum estrogen and luteinizing hormone (LH) concentrations during the mestrual cycle of the rhesus monkey. Endocrinology 89: 177, 1971.PubMedCrossRefGoogle Scholar
  17. 17.
    Abraham G.E., Swerdloff R., Tulchinsky D., Odell W.D. Radioimmunoassay of plasma progesterone. J. Clin. Endocrinol. Metab. 35: 458, 1972.CrossRefGoogle Scholar
  18. 18.
    Odell W.D., Rayford P.L., Ross G.T. Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing and follicle-stimulating hormones. J. Lab. Clin. Med. 70: 973, 1967.PubMedGoogle Scholar
  19. 19.
    Silber R.H., Porter C.C. Determination of 17–21 dihydroxy-20-ketosteroids in the urine and plasma. J. Biol. Chem. 210: 923, 1954.PubMedGoogle Scholar
  20. 20.
    Mattingly D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J. Clin. Pathol. 115: 374, 1962.CrossRefGoogle Scholar
  21. 21.
    Yen S.S.C., Tsai C.C., Naftolin F., Vandenberg G., Ajabor L. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J. Clin. Endocrinol. Metab. 34: 671, 1972.PubMedCrossRefGoogle Scholar
  22. 22.
    L’Hermite M., Caufriez A., Robyn C. Pathophysiology of human prolactin secretion with special references to prolactin-secreting-pituitary adenomas and isolated galactorrhea. In: Crosignani P.G., Robyn C. (Eds.), Prolactin and Human Reproduction Academic Press, New York, 1977, Serono Symposia, vol. 11, p. 225.Google Scholar
  23. 23.
    Gelli D., Liuzzi A., Chiodini P.G., Loli P., Verde G., Botalla L., Silvestrini F. Alcuni aspetti della regolazione neuroumorale delle secrezioni gonadotropica e prolattinica in alcune condizioni patologiche. In: Atti del XVI Congresso della Società Italiana di Endocrinologia, Serono Symposia, Bari, 18–21 maggio 1976, p. 135.Google Scholar
  24. 24.
    Mortimer C.H., Besser G.M., McNeilly A.S., Marshall J.C., Marsoulis P., Tunbridge W.M.G., Gomez-Pan A., Hall R. Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary gonadal-dysfunction. Br. Med. J. II: 73, 1973.CrossRefGoogle Scholar
  25. 25.
    Glass M.R., Shaw R.W., Williams J.W., Butt W.R., Edwards R., London D.R. The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogen and progesterone on the LH and FSH response to LH-RH. Clin. Endocrinol. (Oxf) 5: 521, 1976.CrossRefGoogle Scholar
  26. 26.
    Marshall J.C., Reed P.I., Gordon H. Luteinizing hormone secretion in patients presenting with post-oral contraceptive amenorrhoea: evidence for an hypothalamic feed-back abnormality. Clin. Endocrinol. (Oxf) 5: 131, 1976.CrossRefGoogle Scholar
  27. 27.
    Calaf F. In: Pasteels J.L., Robyn C. (Eds.), Human Prolactin. Excerpta Medica, Amsterdam, 1973, Discussion, p. 221.Google Scholar
  28. 28.
    L’Hermite M., Vekemans M., Caufriez A., Martin-Comin J., Robyn C. Effects of sulpiride induced hyperprolactinemia on human menstrual cycle. Acta Endocrinol. (Suppl) (Kbh) 199, Abstr. 252, p. 312, 1975.Google Scholar
  29. 29.
    Faglia G., Beck-Peccoz P., Travaglini P., Ambrosi B., Rondena M., Paracchi A., Spada A., Weber G., Bara R., Bouzin A. Functional studies in hyperprolactinemic states. In: Crosignani P.G., Robyn C. (Eds.), Prolactin and Human Reproduction. Academic Press, New York, 1977, Serono Symposia, vol. 11, p. 225.Google Scholar
  30. 30.
    Jacobs H.S., Franks S., Murray M.A.F., Hull S.J., Steeie C.J., Nabarro J.D.M. Clinical and endocrine features of hyperprolactinemic amenorrhoea. Clin. Endocrinol. (Oxf) 5: 439, 1976.CrossRefGoogle Scholar
  31. 31.
    Asfour M., L’Hermite M., Hedouin-Quincampoix M., Fossati P. Hypogonadism, galactorrhoea and hyper-prolactinemia: evaluation of pituitary gonadotrophins reserve before and under bromocriptine. Acta Endocrinol. (Kbh) 84: 738, 1977.Google Scholar
  32. 32.
    Lachelin G.C.L., Abu-Fadil S., Yen S.S.C. Functional delineation of hyperprolactinemic amenorrhea. J. Clin. Endocrinol. Metab. 44: 1163, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Del Pozo E., Varga L., Wyss H., Tolis G., Friesen H., Wenner R., Vatter L., Vettwiler A. Clinical and hormonal response to bromocriptine (CB 154) in the galactorrhea syndromes. J. Clin. Endocrinol. Metab. 39: 18, 1974.PubMedCrossRefGoogle Scholar
  34. 34.
    Tyson J.E., Andreasson B., Huth J., Smith B., Zacur H. Neuroendocrine dysfunction in galactorrhea-amenor-rhea after oral contraceptive use. Obstet. Gynecol. 46: 1, 1975.PubMedCrossRefGoogle Scholar
  35. 35.
    Archer D.F., Josimowich H.B. Ovarian response to exogenous gonadotropins in women with elevated serum prolactin. Obstet. Gynecol. 48: 2, 155, 1976.Google Scholar
  36. 36.
    Mroueh A.M., Siler-Khodr T.M. Ovarian refractoriness to gonadotropin in cases of inappropriate lactation: restoration of ovarian function with bromocryptine. J. Clin. Endocrinol. Metab. 43: 1398, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1978

Authors and Affiliations

  • Pietro Travaglini
    • 1
  • B. Ambrosi
    • 1
  • P. Beck-Peccoz
    • 1
  • R. Elli
    • 1
  • M. Rondena
    • 1
  • R. Bara
    • 1
  • G. Weber
    • 1
  1. 1.Second Medical Clinic, Endorine Unit, Pd. SaccoUniversity of MilanoMilanoItaly

Personalised recommendations